# US 2008/0305546 A1 · Method for cultivating tendon cells from pluripotent cells of mesenchymal origin

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305546 A1
- Document ID: US20080305546A1
- Status: Published application
- Kind: A1
- Application number: 12/156,804
- Filed: 2008-06-05
- Published: 2008-12-11
- Earliest claimed: 2007-06-06
- Assignees: Angewandte Biotechnologie GmbH
- Inventors: Hans-Christian Bauer; Herbert Tempfer
- Web page: https://patentgrep.com/patent/US20080305546A1

## CPC

- C12N 5/066: {Tenocytes; Tendons, Ligaments}
- C12N 2502/13: connective tissue cells; generic mesenchyme cells, e.g. so-called "embryonic fibroblasts"
- C12N 2502/1305: Adipocytes
- C12N 2502/1311: Osteocytes, osteoblasts, odontoblasts
- C12N 2502/1317: Chondrocytes
- C12N 2502/1323: Adult fibroblasts
- C12N 2502/1329: Cardiomyocytes
- C12N 2502/1335: Skeletal muscle cells, myocytes, myoblasts, myotubes
- C12N 2502/1341: Tenocytes, cells from tendons and ligaments
- C12N 2502/1347: Smooth muscle cells
- C12N 2502/1352: Mesenchymal stem cells
- C12N 2502/1358: Bone marrow mesenchymal stem cells (BM-MSC)
- C12N 2502/1364: Dental pulp stem cells, dental follicle stem cells
- C12N 2502/137: Blood-borne mesenchymal stem cells, e.g. Msc from umbilical cord blood
- C12N 2502/1376: Mesenchymal stem cells from hair follicles
- C12N 2502/1382: Adipose-derived stem cells [ADSC], adipose stromal stem cells
- C12N 2502/1388: Mesenchymal stem cells from other natural sources
- C12N 2502/1394: Bone marrow stromal cells; whole marrow
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A method for cultivating tendon cells from non-embryonic pluripotent cells of mesenchymal origin is described, wherein the isolated cells are cultivated in a culture medium under standard culture conditions in a culture vessel. In order to increase the collagen secretion, it is proposed that before their complete confluence, the cells are on the one hand further cultivated in a culture medium mixed with ascorbic acid and/or ascorbic acid-2-phosphate in a concentration of 25 to 75 μg/ml and on the other hand, subjected to hyperosmolar treatment in a culture medium whose osmolarity is adjusted to 350 to 500 mosmol/l.

## Claims

### Claim 1

A method for cultivating tendon cells from non-embryonic pluripotent cells of mesenchymal origin, wherein the isolated cells are cultivated in a culture medium under standard culture conditions in a culture vessel, wherein before their complete confluence, the cells are on the one hand further cultivated in a culture medium mixed with ascorbic acid and/or ascorbic acid-2-phosphate in a concentration of 25 to 75 μg/ml and on the other hand, subjected to hyperosmolar treatment in a culture medium whose osmolarity is adjusted to 350 to 500 mosmol/l.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the hyperosmolar treatment of the cells and their treatment with ascorbic acid or ascorbic acid-2-phosphate takes place simultaneously.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the hyperosmolar treatment of the cells takes place in a culture medium whose osmolarity is adjusted to 350 to 400 mosmol/l.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the cells are cultivated in primary culture under standard culture conditions and are passaged before their confluence, then preferably the first passage is cultivated further under standard culture conditions as far as the logarithmic growth phase before the cells are treated with ascorbic acid or ascorbic acid-2-phosphate under hyperosmolar conditions.
